International Pharmaceutical Excipients Council
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 1,153,815 | 1,199,812 | −45,997 | 0.6 | 24% |
| 2012 | 1,126,980 | 1,114,605 | 12,375 | 0.7 | 22% |
| 2013 | 1,458,755 | 895,505 | 563,250 | 8.5 | 29% |
| 2014 | 1,119,533 | 846,048 | 273,485 | 12.8 | 31% |
| 2015 | 1,153,481 | 914,240 | 239,241 | 15.0 | 37% |
| 2016 | 1,222,243 | 976,549 | 245,694 | 17.1 | 35% |
| 2017 | 1,194,687 | 995,687 | 199,000 | 19.4 | 36% |
| 2018 | 1,017,731 | 1,080,967 | −63,236 | 16.7 | 30% |
| 2019 | 1,221,153 | 1,241,094 | −19,941 | 15.2 | 25% |
| 2020 | 1,025,233 | 1,088,556 | −63,323 | 17.2 | 39% |
| 2021 | 1,112,656 | 1,069,780 | 42,876 | 19.0 | 37% |
| 2022 | 1,449,076 | 1,538,026 | −88,950 | 11.0 | 27% |
| 2023 | 1,404,333 | 1,537,299 | −132,966 | 10.9 | 27% |
In its most recent public year (2023), this organization spent $132,966 more than it brought in. Its reserves stood at about 10.9 months of spending, up from 0.6 in 2011. Staff pay was 27% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works